Thymalin
Thymalin (Thymic Polypeptide Extract)
Thymalin is a polypeptide extract from the thymus glands of young calves, standardised for thymic peptide content. It was developed at the St. Petersburg Institute of Biogerontology and used in the landmark Russian longitudinal longevity studies. As the thymus involutes (shrinks) with age, thymalin aims to compensate for the loss of thymic peptide signalling that drives T-cell maturation and immune competence. It is the natural precursor concept from which synthetic Thymosin Alpha-1 (Tα1) was derived.
Mechanism of Action
Thymalin contains a complex mixture of thymic peptides that collectively support T-lymphocyte differentiation, maturation, and functional activation. The primary active components include thymulin, thymosin alpha-1, thymosin beta-4, and other thymic factors — providing broader thymic peptide coverage than synthetic single-compound alternatives.
By supplementing the declining thymic peptide output that accompanies thymic involution, Thymalin aims to maintain the T-cell repertoire, NK cell activity, and immune surveillance functions that decrease with age. This immune restoration is the primary mechanism underlying the longevity and cancer-prevention outcomes observed in the Russian clinical data.
Thymalin's complexity (multiple peptide components vs a single synthetic peptide) may provide advantages in terms of completeness of thymic function restoration, but also makes it less precisely characterised than synthetic alternatives like Thymosin Alpha-1.
Research Evidence
Thymalin is the thymic component of the pivotal Russian longevity research programme by Khavinson and Anisimov. The 25-year longitudinal studies using Thymalin + Epithalamin represent the most extended human peptide longevity intervention data in existence.
25-Year Follow-Up: Thymalin + Epithalamin in Elderly Cohort
266 elderly patients receiving biannual courses of Thymalin + Epithalamin over 12 active treatment years showed 2-fold reduction in mortality, reduced cardiovascular and oncological events, preserved neuropsychological function, and improved hormonal parameters versus matched controls.
Typical Research Protocol
The traditional Russian protocol: 10–20 mg total thymalin divided over 10 daily IM injections (1–2 mg/day) twice yearly. Some practitioners substitute synthetic Thymosin Alpha-1 (1.6mg 2× weekly) as a more precisely dosed modern equivalent. The combination with Epithalon (or Epithalamin) mirrors the original research protocol most closely.
Safety Profile
Reported Side Effects
- Injection site pain (IM)
- Mild flu-like symptoms (immune activation)
- Fatigue (first few days)
- Mild fever (rare)
Contraindications
- Active autoimmune disease
- Post-transplant immunosuppression
- Known bovine/porcine sensitivity
- Pregnancy
Common Research Stacks
Frequently Asked Questions
What is the difference between Thymalin and Thymosin Alpha-1?
Thymalin is a complex natural extract from calf thymus containing multiple thymic peptides. Thymosin Alpha-1 (Tα1) is a single, precisely characterised 28-amino-acid synthetic peptide — the most studied and clinically validated component of thymic function. Tα1 is more precisely dosed, has pharmaceutical-grade purity (Zadaxin), and has individual RCT evidence. Thymalin provides broader thymic factor coverage but is less precisely characterised.
Is Thymalin the same compound used in the Russian longevity studies?
Yes — Thymalin (thymic extract) was one of the two compounds in the landmark Russian longitudinal research (with Epithalamin as the pineal extract). The 25-year follow-up data showing 2-fold mortality reduction and reduced cancer incidence was generated specifically with Thymalin + Epithalamin. Most modern practitioners use synthetic Tα1 + synthetic Epithalon as more precise equivalents.
How does Thymalin support immunity in ageing?
The thymus involutes progressively from puberty, producing fewer T-cells with each decade. By age 60, thymic output is approximately 5% of peak. This "immunosenescence" drives rising susceptibility to infections, reduced vaccine responses, impaired anti-tumour surveillance, and increased autoimmune pathology. Thymalin compensates for declining thymic peptide output, supporting T-cell repertoire maintenance and NK cell activity.
Can Thymalin be substituted with Thymosin Alpha-1?
Most modern longevity practitioners use Tα1 as the synthetic substitute for Thymalin due to better characterisation, pure single-compound composition, and pharmaceutical-grade quality control (Zadaxin). The research suggests Tα1 captures most of Thymalin's key immune benefits. However, Thymalin's complexity may provide additional thymosin beta-4, thymulin, and other thymic factor benefits not covered by Tα1 alone.
When is the best time of year to do a Thymalin course?
The Russian protocol used biannual courses — traditionally spring (March–April) and autumn (September–October). Timing around seasonal infection peaks (autumn before cold/flu season) and spring immune recalibration mirrors natural seasonal immune variation. There is no definitive evidence that specific timing is critical, but this biannual rhythm aligns with the published outcome data.
Key Research References
- Khavinson VKh et al. (2009). Peptide regulation of aging: 35-year research experience. Bull Exp Biol Med.
- Anisimov VN, Khavinson VKh. (2010). Peptide bioregulation of aging: Results and prospects. Ageing Res Rev.
Explore more Longevity research compounds
Browse Longevity →